These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22705708)

  • 1. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
    Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
    McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
    Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.
    Thompson CM; Seiter J; Chappell MA; Tappero RV; Proctor DM; Suh M; Wolf JC; Haws LC; Vitale R; Mittal L; Kirman CR; Hays SM; Harris MA
    Toxicol Sci; 2015 Jan; 143(1):16-25. PubMed ID: 25352572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water.
    Kopec AK; Kim S; Forgacs AL; Zacharewski TR; Proctor DM; Harris MA; Haws LC; Thompson CM
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):13-26. PubMed ID: 22155349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia.
    Kopec AK; Thompson CM; Kim S; Forgacs AL; Zacharewski TR
    Toxicol Appl Pharmacol; 2012 Jul; 262(2):124-38. PubMed ID: 22561333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
    Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
    Proctor DM; Suh M; Campleman SL; Thompson CM
    Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracing the tracks of genotoxicity by trivalent and hexavalent chromium in Drosophila melanogaster.
    Mishra M; Sharma A; Negi MP; Dwivedi UN; Chowdhuri DK
    Mutat Res; 2011 May; 722(1):44-51. PubMed ID: 21382505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue® rats.
    Thompson CM; Young RR; Dinesdurage H; Suh M; Harris MA; Rohr AC; Proctor DM
    Toxicol Appl Pharmacol; 2017 Sep; 330():48-52. PubMed ID: 28687238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water.
    O'Brien TJ; Ding H; Suh M; Thompson CM; Parsons BL; Harris MA; Winkelman WA; Wolf JC; Hixon JG; Schwartz AM; Myers MB; Haws LC; Proctor DM
    Mutat Res; 2013 Jun; 754(1-2):15-21. PubMed ID: 23583686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium.
    Thompson CM; Proctor DM; Haws LC; Hébert CD; Grimes SD; Shertzer HG; Kopec AK; Hixon JG; Zacharewski TR; Harris MA
    Toxicol Sci; 2011 Sep; 123(1):58-70. PubMed ID: 21712504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy.
    Thompson CM; Wolf JC; Elbekai RH; Paranjpe MG; Seiter JM; Chappell MA; Tappero RV; Suh M; Proctor DM; Bichteler A; Haws LC; Harris MA
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():61-6. PubMed ID: 26232259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice.
    Cheng L; Sonntag DM; de Boer J; Dixon K
    J Environ Pathol Toxicol Oncol; 2000; 19(3):239-49. PubMed ID: 10983890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of nonmutagenic Cr(III)-DNA interactions.
    Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
    Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents.
    Thompson CM; Suh M; Proctor DM; Haws LC; Harris MA
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Nov; 823():45-57. PubMed ID: 28985946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats.
    Thompson CM; Young RR; Suh M; Dinesdurage HR; Elbekai RH; Harris MA; Rohr AC; Proctor DM
    Environ Mol Mutagen; 2015 Aug; 56(7):621-8. PubMed ID: 26010270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromium in drinking water: sources, metabolism, and cancer risks.
    Zhitkovich A
    Chem Res Toxicol; 2011 Oct; 24(10):1617-29. PubMed ID: 21766833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
    Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
    J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.
    Thompson CM; Wolf JC; McCoy A; Suh M; Proctor DM; Kirman CR; Haws LC; Harris MA
    Toxicol Pathol; 2017 Dec; 45(8):1091-1101. PubMed ID: 29161989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.